Showing results (321-330 of 782) with videos related to
Sort By:
Pageof 79
The Lancet. HIV|July 19, 2017
Effect of ageing on neurocognitive function by stage of HIV infection: evidence from the Multicenter AIDS Cohort StudyKarl Goodkin, Eric N Miller, Christopher Cox, et al.The Lancet. HIV|August 9, 2017
Comparative efficacy and safety of second-line antiretroviral therapy for treatment of HIV/AIDS: a systematic review and network meta-analysisSteve Kanters, Maria Eugenia Socias, Nicholas I Paton, et al.The Lancet. HIV|November 7, 2017
Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysisHelen Kelly, Helen A Weiss, Yolanda Benavente, et al.The Lancet. HIV|October 6, 2017
Detection and treatment of Fiebig stage I HIV-1 infection in young at-risk women in South Africa: a prospective cohort studyKrista L Dong, Amber Moodley, Douglas S Kwon, et al.The Lancet. HIV|August 28, 2017
The Amagugu intervention for disclosure of maternal HIV to uninfected primary school-aged children in South Africa: a randomised controlled trialTamsen J Rochat, Alan Stein, Mario Cortina-Borja, et al.The Lancet. HIV|March 5, 2016
A hybrid mobile approach for population-wide HIV testing in rural east Africa: an observational studyGabriel Chamie, Tamara D Clark, Jane Kabami, et al.The Lancet. HIV|November 29, 2015
HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trialMadeline B Deutsch, David V Glidden, Jae Sevelius, et al.The Lancet. HIV|July 2, 2016
Interventions to strengthen the HIV prevention cascade: a systematic review of reviewsShari Krishnaratne, Bernadette Hensen, Jillian Cordes, et al.The Lancet. HIV|December 23, 2014
Understanding the HIV disparities between black and white men who have sex with men in the USA using the HIV care continuum: a modeling studyEli S Rosenberg, Gregorio A Millett, Patrick S Sullivan, et al.The Lancet. HIV|May 27, 2017
Safety and tolerability of long-acting cabotegravir injections in HIV-uninfected men (ECLAIR): a multicentre, double-blind, randomised, placebo-controlled, phase 2a trialMartin Markowitz, Ian Frank, Robert M Grant, et al.Pageof 79